Global Gums (Chewing Gum and Bubble Gum) Industry
/
Date12 Jul 2020
Email Print Friendly Share New York, July 11, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Gums (Chewing Gum and Bubble... Read More →
Gilat Intends to File Counterclaims Seeking Enforcement of the Merger Agreement or Hundreds of Millions of Dollars in Monetary Damages following Comtech’s Filing of an Amended Complaint
/
Date12 Jul 2020
Email Print Friendly Share PETAH TIKVA, Israel, July 12, 2020 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite... Read More →
Shaw Declares Dividend Payable on Preferred Shares
/
Date12 Jul 2020
Email Print Friendly Share CALGARY, Alberta, July 10, 2020 (GLOBE NEWSWIRE) — Shaw Communications Inc. (“Shaw”) announced today that its Board of Directors has declared... Read More →
Shaw Announces Third Quarter and Year-to-Date Fiscal 2020 Results
/
Date12 Jul 2020
Email Print Friendly Share Solid third quarter financial performance amidst the COVID-19 pandemic showcases critical nature of robust connectivity infrastructure and overall business resiliency during... Read More →
Cancer Cachexia Market to Reach USD 2.93 Billion by 2027; Rapid Inclination towards Combination Therapies to Aid Growth: Fortune Business Insights™
/
Date12 Jul 2020
Email Print Friendly Share Pune, July 10, 2020 (GLOBE NEWSWIRE) — The global cancer cachexia market is anticipated to gain traction from the rising shift... Read More →
Bergman & Beving AB: Årsredovisning 2019/2020 offentliggjord
/
Date12 Jul 2020
Email Print Friendly Share Pressmeddelande Årsredovisning 2019/2020 offentliggjord Bergman & Bevings årsredovisning för räkenskapsåret 1 april 2019 – 31 mars 2020 har idag publicerats på... Read More →
Vir Biotechnology Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
/
Date12 Jul 2020
Email Print Friendly Share SAN FRANCISCO, July 10, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and... Read More →